- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
U.S. FDA Grants Priority Review for XARELTO® (rivaroxaban) Supplemental NDAs for the Treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and the Long-Term Prevention of Recurrent DVT and PE
Company Also Provides Update on Stent Thrombosis sNDA
VELCADE® Receives Positive Regulatory Recommendation in the European Union for Subcutaneous Administration
New route of administration provides improved safety and greater convenience for patients and healthcare professionals
Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
Collaboration between researchers led to major impact on understanding gene regulation
Janssen Submits Additional Marketing Applications for ZYTIGA® In the U.S. and European Union
Simultaneous Submissions Based on Data from Pre-chemo Prostate Cancer Study
Positive Results from First Human Clinical Trials of a First-Generation Artificial Pancreas System is Significant Step Forward for Millions with Type 1 Diabetes
System in Development from Animas-JDRF Partnership Successfully Detects Highs and Lows, and Shown to Safely and Automatically Adjust Insulin Delivery in Clinical Setting